Primary Immune Deficiency Treatment Consortium — Christopher Craig Dvorak (UNIVERSITY OF CALIFORNIA, SAN FRANCISCO)
ABSTRACT/SUMMARY The Primary Immune Deficiency Treatment Consortium (PIDTC), an RDCRN consortium of 44 immunology and hematopoietic stem cell transplant centers throughout the USA and Canada, was esta
| Project title | Primary Immune Deficiency Treatment Consortium |
|---|---|
| Project number | 5U54AI082973-14 |
| PI name | Christopher Craig Dvorak |
| Institution | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO |
| Funding mechanism | U54 |
| Agency | NIAID |
| Award amount | $1.85M |
| Fiscal year | 2022 |
| Project start | 2009-09-12T00:00:00 |
| Project end | 2024-08-31T00:00:00 |
| Abstract | ABSTRACT/SUMMARY The Primary Immune Deficiency Treatment Consortium (PIDTC), an RDCRN consortium of 44 immunology and hematopoietic stem cell transplant centers throughout the USA and Canada, was esta |
| Key terms | <Address><Adverse Late Effects><Affect><Age of Onset><Aldrich Syndrome><Autoimmune><B blood cells><B |
$799/mo
Try GrantRadar →